Senti Biosciences Holdings (SNTI) Interest & Investment Income (2021 - 2025)
Senti Biosciences Holdings (SNTI) recorded quarterly Interest & Investment Income of $97000.0 in Q4 2025, down 41.57% quarter-over-quarter from $166000.0 in Q3 2025, and down 57.83% on a YoY basis from $230000.0 in Q4 2024.
Senti Biosciences Holdings (SNTI) Interest & Investment Income (2021 - 2025) Analysis & Trends
Senti Biosciences Holdings' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $97000.0 for Q4 2025.
- In Q4 2025, Interest & Investment Income fell 57.83% year-over-year to $97000.0; the TTM figure through Dec 2025 stood at $927000.0 (down 2.11% YoY), while the FY2025 annual figure was $927000.0, down 2.22% from the prior year.
- Interest & Investment Income was $97000.0 for Q4 2025 at Senti Biosciences Holdings, down from $166000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.1 million in Q4 2022 to a low of $2000.0 in Q2 2021.
- Historically, Interest & Investment Income has averaged $339725.5 across 5 years, with a median of $236000.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income soared 26425.0% in 2023, then tumbled 74.27% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $8784.0 in 2021, then jumped by 12741.53% to $1.1 million in 2022, then plunged by 62.23% to $426000.0 in 2023, then plunged by 46.01% to $230000.0 in 2024, then sank by 57.83% to $97000.0 in 2025.
- The last three Interest & Investment Income figures came in at $97000.0 (Q4 2025), $166000.0 (Q3 2025), and $270000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -14.79 Mn |
| 10 | Senti Biosciences Holdings | 21.36 Mn | 21.36 Mn | - | 97,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 97,000.00 |
| Sep 30, 2025 | 166,000.00 |
| Jun 30, 2025 | 270,000.00 |
| Mar 31, 2025 | 394,000.00 |
| Dec 31, 2024 | 230,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 236,000.00 |
| Mar 31, 2024 | 331,000.00 |
| Dec 31, 2023 | 426,000.00 |
| Sep 30, 2023 | 583,000.00 |
| Jun 30, 2023 | 794,000.00 |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 542,000.00 |
| Jun 30, 2022 | 27,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 8,784.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 2,000.00 |